At-Home cervical cancer screening could save lives in rural uganda

NCT ID NCT04927650

Ongoing Prevention Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether women in rural Uganda can screen themselves for cervical cancer using a simple HPV test at home. Over 2,500 women aged 25-49 will collect their own samples during community health campaigns. The goal is to see if this approach increases screening rates and helps catch precancerous changes early, potentially preventing cervical cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HPV testing
What this could lead to: If successful, this could make cervical cancer screening more accessible in low-resource communities, helping detect precancerous changes earlier.
What could go wrong: This is an observational study, not a treatment trial. It measures screening uptake and outcomes, so it won't directly test a cure or new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical carcinoma human papillomavirus-related squamous cell carcinoma Uterine Cervical Neoplasms cervical cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CARCINOMA HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA

Contacts and locations

Locations

Makerere University College of Health Sciences School of Medicine

Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.